Matricelf Ltd (TA:MTLF) — Market Cap & Net Worth
Market Cap & Net Worth: Matricelf Ltd (MTLF)
Matricelf Ltd (TA:MTLF) has a market capitalization of $20.82 Million (ILA7.77 Billion) as of September 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #25077 globally and #358 in its home market, demonstrating a -11.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Matricelf Ltd's stock price ILA265.60 by its total outstanding shares 29244761 (29.24 Million). Also see Matricelf Ltd asset portfolio for a full breakdown of the balance sheet.
Matricelf Ltd Market Cap History: 2021 to 2026
Matricelf Ltd's market capitalization history from 2021 to 2026. Data shows change from $67.46 Million to $20.82 Million (-12.30% CAGR). Also see MTLF cash flow conversion for how efficiently the company converts equity into cash flow.
Matricelf Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Matricelf Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MTLF stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MTLF by Market Capitalization
Companies near Matricelf Ltd in the global market cap rankings as of September 17, 2026. Review Matricelf Ltd tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Matricelf Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Matricelf Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Matricelf Ltd's market cap moved from $67.46 Million to $ 20.82 Million, with a yearly change of -12.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA20.82 Million | -51.79% |
| 2025 | ILA43.19 Million | +50.27% |
| 2024 | ILA28.74 Million | -11.51% |
| 2023 | ILA32.48 Million | -7.15% |
| 2022 | ILA34.98 Million | -48.14% |
| 2021 | ILA67.46 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Matricelf Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.82 Million USD |
| MoneyControl | $20.82 Million USD |
| MarketWatch | $20.82 Million USD |
| marketcap.company | $20.82 Million USD |
| Reuters | $20.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more